Stock Earnings

Question 1

What are Valeo Pharma Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Valeo Pharma Inc has a total asset of $41, Net loss of $-27

Question 2

What are the key financial ratios for VPHIF?

Accepted Answer

Valeo Pharma Inc's Current ratio is 0.5, has a Net margin is -50.94, sales per share of $0.61.

Question 3

How is Valeo Pharma Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Valeo Pharma Inc data is not available.

Question 4

Is Valeo Pharma Inc profitable?

Accepted Answer

no, according to the latest financial statements, Valeo Pharma Inc has a net loss of $-27

Question 5

Does Valeo Pharma Inc have any liabilities?

Accepted Answer

yes, Valeo Pharma Inc has liability of 81

Question 6

How many outstanding shares for Valeo Pharma Inc?

Accepted Answer

Valeo Pharma Inc has a total outstanding shares of 98.63

Breakdown	TTM	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019
Revenue	53	53	27	13	7	6
Revenue Growth (YoY)	0%	96%	108%	86%	17%	50%
Cost of Revenue	44	40	21	9	6	5
Gross Profit	8	13	6	3	1	1
Selling, General & Admin	27	29	25	16	5	5
Research & Development	--	--	--	--	0	0
Operating Expenses	27	30	25	16	5	5
Other Non Operating Income (Expenses)	4	2	0	0	0	0
Pretax Income	-32	-27	-26	-14	-4	-3
Income Tax Expense	--	0	-1	0	0	0
Net Income	-32	-27	-25	-14	-4	-3
Net Income Growth	14%	8%	79%	250%	33%	50%
Shares Outstanding (Diluted)	98.67	86.11	80.85	69.93	57.9	49.58
Shares Change (YoY)	17%	7%	16%	21%	17%	39%
EPS (Diluted)	-0.34	-0.32	-0.31	-0.2	-0.08	-0.07
EPS Growth	-1%	1%	56%	148%	13%	7%
Free Cash Flow	-9	-21	-35	-15	-6	-3
Free Cash Flow Per Share	-0.09	-0.24	-0.43	-0.21	-0.1	-0.06
Gross Margin	15.09%	24.52%	22.22%	23.07%	14.28%	16.66%
Operating Margin	-35.84%	-32.07%	-70.37%	-92.3%	-57.14%	-50%
Profit Margin	-60.37%	-50.94%	-92.59%	-107.69%	-57.14%	-50%
Free Cash Flow Margin	-16.98%	-39.62%	-129.62%	-115.38%	-85.71%	-50%
EBITDA	-17	-15	-18	-12	-4	-3
EBITDA Margin	-32.07%	-28.3%	-66.66%	-92.3%	-57.14%	-50%
D&A For EBITDA	2	2	1	0	0	0
EBIT	-19	-17	-19	-12	-4	-3
EBIT Margin	-35.84%	-32.07%	-70.37%	-92.3%	-57.14%	-50%
Effective Tax Rate	--	0%	3.84%	0%	0%	0%

Valeo Pharma Inc (VPHIF) Price